PROJECT RESONANCE™ · EF RESONATOR · WHOLE-BODY PEMF

Engineer trust into
every session.

The EF Resonator is a programmable whole-body electromagnetic wellness and research platform — built around documented output, repeatable protocols, careful claims, and a clear path from prototype to pilot deployment.

Whole-BodyField Coverage
ProgrammableSession Control
MeasurableDocumented Output
UpgradableModular Platform
EF RESONATORWHOLE-BODY PEMFPROGRAMMABLEMEASURABLERESEARCH-READYPROJECT RESONANCE

01 · THE PLATFORM

Engineered around
precision electromagnetic fields.

The EF Resonator integrates three layers in one configurable platform: a whole-body coil bed, a programmable control system, and a research-ready data layer — with real-time monitoring and safety systems throughout.

01Whole-body bedMulti-zone coil architecture, thermal monitoring, emergency shutoff, and serviceable modules.
02Control systemProgrammable frequency, intensity, and duration with preset protocols and session logging.
03Research layerControlled parameters, de-identified outcomes, remote updates, and future sensor inputs.
04Commercial workflowTouchscreen operation designed for clinics, studios, performance facilities, and research environments.
Project Resonance whole-body PEMF system

02 · THE EXPERIENCE

One platform. One streamlined session.

A clean, guided experience built around comfort, consistency, and repeatable operation.

01

Select a Session

Choose a preset or operator-defined program based on the intended wellness or recovery objective.

02

Settle In

The user lies comfortably on the padded platform while the system performs status and safety checks.

03

Run the Protocol

The controller delivers the programmed PEMF session while timing and system conditions are monitored.

04

Review & Repeat

Usage data and session history can support consistent operating protocols and future software development.

03 · DESIGNED FOR MODERN WELLNESS

Built for people who ask more from their bodies.

Initial markets follow where premium wellness is already purchased: longevity, chiropractic, physical-therapy and sports-recovery clinics; premium gyms, recovery centers and professional teams; and universities and investigators who need configurable field delivery.

PERFORMANCE

Athletes & Strength Training

Recovery-focused programming for gyms, training facilities, and performance centers.

ACTIVE LIFESTYLE

Fitness & Wellness

A premium recovery and relaxation experience for wellness studios and active clients.

WORKFORCE

Physical Labor & Recovery

Designed for demanding occupations where soreness, fatigue, and recovery time matter.

04 · CORE SYSTEM FEATURES

Built to become a serious commercial platform.

Wide Frequency Control

Programmable output architecture intended to support validated protocol development.

Touchscreen Console

Operator-friendly interface for session setup — proposed 5–60 minute programs with countdown, pause, and controlled stop.

Field Monitoring

Designed around measurable electromagnetic output rather than frequency alone.

Thermal Protection

Coil and electronics monitoring with automatic fault handling and shutdown logic.

Safety Interlocks

Emergency controls, current limits, electrical isolation, and operating safeguards.

Software-Ready

Fifteen named preset slots, protocol libraries, diagnostics, session logging, and future cloud features.

05 · FOR BUSINESS

A platform designed for
premium wellness economics.

Project Resonance is positioned for wellness centers, athletic recovery facilities, clinics operating within applicable regulations, corporate recovery programs, research partners, and multi-location operators.

Hardware sales · $150K–$250K target range Leasing · $4K–$8K monthly target Recurring service, software & data tools Training & operator certification Multi-location deployment Research partnerships

Preliminary model — customer discovery will determine the best mix of ownership, leasing, and recurring revenue.

Business & Investor Inquiry

SERIES A · AUGUST 2026

Milestone-based funding to prototype, validation, and pilot readiness.

$15M
Capital released against verified technical gates, with board-level governance of claims, risk, and spending.
Engineering + prototype35%
Testing + regulatory20%
Clinical + research evidence15%
Software + data platform12%
Team + operations10%
Contingency + working capital8%

Proposed allocation; final budget follows engineering quotations and regulatory counsel. Pricing, adoption, margins, and timing must be validated through prototype and customer discovery.

06 · DEVELOPMENT ROADMAP

Three gates lead to pilot readiness.

Engineering and validation first — commercial expansion follows measurable readiness gates, with capital released only against verified deliverables.

0–9 MO

Engineer

Requirements, simulation, risk analysis, alpha prototype, and supplier plan.

9–18 MO

Validate

Beta units, safety and usability testing, design iteration, and the regulatory decision.

18–30 MO

Pilot

Limited production, reference sites, service model, and the commercial-readiness decision.

The commercial ramp follows the same discipline: 5–10 pilot sites, then 20–30 reference sites, then channel growth through clinic groups, distributors, and research partners.

07 · EVIDENCE

Evidence development is part of the product.

Published PEMF research reports mixed, protocol-dependent results — and existing literature does not establish that any new platform is safe or effective for a specific condition. So no claim gets ahead of device-specific evidence: every session is measurable, logged, and repeatable, and validation proceeds in order.

BENCH

Verify Output

Field mapping, electrical safety, thermal behavior, repeatability, and EMC.

HUMAN FACTORS

Verify Use

Training, contraindications, labeling, workflow, and adverse-event capture.

STUDIES

Verify Claims

Prospective protocols designed with independent investigators and regulatory counsel.

Launch conservatively; expand with evidence — general wellness positioning first, research partnerships second, and specific indications pursued only with evidence and the appropriate FDA pathway.

08 · THE VISION

Project Resonance™

The mission is straightforward: build a premium, credible, measurable whole-body PEMF platform that feels as advanced as the technology inside it.

Founder Robert Merrill is an experienced entrepreneur and former chief executive who founded and operated approximately fifteen companies with a combined workforce of about 3,000 employees — spanning logging, sawmill operations, commercial fishing, and heavy equipment. He brings that operating discipline to Project Resonance, supported by a planned advisory bench across electromagnetics engineering, independent science, regulatory and quality, and manufacturing, appointed as the program scales.

“Build it right. Validate it. Make it simple to use. Then scale it.”

ROBERT MERRILL · FOUNDER & OWNER · PROJECT RESONANCE™

10 · COMMON QUESTIONS

What people want to know first.

What is Project Resonance?

Project Resonance is a whole-body programmable PEMF platform concept designed around controllable electromagnetic fields, a treatment bed, large coil assemblies, electronic monitoring, and a modern commercial user experience.

Is this a replacement for medical care?

No. The website presents Project Resonance as a wellness and technology platform. It is not intended to replace diagnosis, treatment, or medical care. Any medical-device claims or indications would require appropriate testing, evidence, and regulatory authorization.

Who is the system intended for?

The commercial vision includes wellness centers, performance and recovery facilities, research environments, fitness operators, and other organizations that can use the system within applicable laws and professional standards.

Where does the science stand?

Published PEMF studies report potentially useful signals in selected musculoskeletal contexts, but results vary by device, protocol, and study quality — and existing literature does not establish that the EF Resonator is safe or effective for any condition. The development program treats that honestly: bench characterization, human-factors work, and independent studies come before any claim.

How is development funded?

Project Resonance is raising a $15M Series A (August 2026), released in stages against verified technical milestones, to reach prototype, validation, and pilot readiness over approximately 30 months. Use of funds spans engineering and prototype, testing and regulatory, clinical and research evidence, software and data, team, and contingency.

Can I inquire about purchasing or partnering?

Yes. Use the contact form below for product, partnership, investor, distribution, or facility inquiries.

REQUEST INFORMATION

Bring Project Resonance
into your market.

Tell us whether you are interested in ownership, partnerships, investment, research, distribution, or a future demonstration.

Submitting opens your email app with the inquiry pre-filled — or write directly to robertamerrill65@gmail.com.